IP Library Granted Patent US 9,671,399
Granted Patent B2
US 9,671,399 · App. 15/205,029 · Granted Jun 6, 2017

Lateral flow assay devices for use in clinical diagnostic apparatus and configuration of clinical diagnostic apparatus for same

Inventors: Raymond F. Jakubowicz (Rush, NY); Randy K. Bower (Pittsford, NY); Joseph J. Dambra (Rochester, NY); Zhong Ding (Pittsford, NY); James E. Robinson (Rochester, NY); Dale R. Ryan (Fairport, NY); David A. Tomasso (Rochester, NY)
Assignee: Ortho-Clinical Diagnostics, Inc.
G01N33/54386G01N35/00069G01N35/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,671,399
App. No.
15/205,029
Granted
Jun 6, 2017
Kind
B2
Abstract

A lateral flow device for use in a mainframe or point-of-care clinical analyzer, in which the lateral flow device includes a planar support having at least one sample addition area and at least one reaction area disposed thereon. The sample addition area and reaction area are fluidly interconnected to one another and form at least one lateral fluid flow path. The lateral flow device is sized for retention within a storage cartridge of the analyzer defined by a hollow interior and having a plurality of lateral flow assay devices retained in stacked relation therein.

Claims (19)

1. A method for processing analytical test elements in a clinical analyzer, said method comprising the steps of:

introducing a first plurality of analytical test elements into said clinical analyzer, said first plurality comprising lateral flow assay devices each comprising a support, at least one sample addition area, at least one reagent area, at least one detection area, and at least one wicking area, each of said areas being fluidly interconnected to one another to define at least one linear fluid flow path;

dispensing a volume of sample onto the sample addition area of at least one of said plurality of lateral flow assay devices, wherein the sample is caused to move along the at least one fluid path under capillary action and in which a detectable signal is produced when the moving sample is combined with material in the reaction zone for detection of the detectable signal in the at least one detection area;

advancing the at least one lateral flow assay device into an incubator of the clinical analyzer;

incubating said at least one lateral flow assay device;

aligning the at least one lateral flow device with a fluorimeter disposed within the incubator; and

scanning a linear portion of the detection area of the at least one lateral flow device within the incubator for the presence of the detectable signal from said at least one lateral flow assay device using the fluorimeter.

2. A method as recited in claim 1 , wherein said introducing step includes the step of loading a storage cartridge retaining the plurality of said lateral flow assay devices in stacked relation in the storage cartridge into the analyzer.

3. A method as recited in claim 1 , wherein said dispensing step includes the step of aspirating a quantity of sample from a sample supply of said analyzer using a metering mechanism and dispensing at least a portion of said aspirated sample onto the sample addition area of said at least one lateral flow assay device.

4. A method as recited in claim 1 , wherein said advancing step includes the step of shuttling said at least one lateral flow assay device from a dispensing station into a receiving station of said incubator.

5. A method as recited in claim 1 , wherein said shuttling step is performed by a reciprocating pusher blade assembly.

6. A method as recited in claim 1 , wherein each said lateral flow assay device includes a plurality of projections extending upwardly from a top surface of said support, said plurality of projections having a center to center spacing and having height and diameter dimensions configured to enable the capillary flow of sample applied to said sample addition area along the at least one fluid flow path.

7. A method as recited in claim 1 , including the additional step of introducing a second plurality of analytical test elements to the clinical analyzer, said second plurality comprising a plurality of thin-film slide elements, said method further including the steps of dispensing a quantity of sample onto a sample addition area of at least one of the plurality of said thin-film slide elements, sequentially advancing the at least one thin-film slide element into the incubator, incubating the at least one thin-film slide elements and detecting of at least one test result relating thereto.

8. A method as recited in claim 7 , including the further step of interchangeably handling the processing of the first and second pluralities of analytical test elements by said incubator of the clinical analyzer.

9. A method as recited in claim 1 , including the additional step of providing a wet chemistry assay system on said clinical analyzer.

10. A method as recited in claim 1 , in which the analyzer is at least one of a point of care analyzer and an automated clinical analyzer.

11. A method as recited in claim 4 , in which the incubator is defined by a pair of concentric rings, each of the rings including receiving stations disposed circumferentially about a center axis, the rings being rotatable about the center axis.

12. The method as recited in claim 11 , in which the fluorimeter is disposed within and adjacent the center of a housing of the incubator, the method including the steps of initially receiving the at least one lateral flow device in a receiving station of an outer ring of the incubator, shuttling the at least one lateral flow device to a receiving station in the inner ring, and aligning the at least one lateral flow device for detection by scanning of the fluorimeter for detection of the detectable signal.

13. The method as recited in claim 12 , wherein the material in the reagent area produces a fluorescent signal when mixed with the moving sample, the method including the step of using the fluorimeter to detect the fluorescent signal in the detection zone of the at least one lateral flow device.

Assignments (4)
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY AGREEMENT Recorded Nov 6, 2018
From: ORTHO-CLINICAL DIAGNOSTICS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 047435/0065 →
Continuity (4)
Division 13914678 · Jun 11, 2013
Provisional Application 61658698 · Jun 12, 2012
Provisional Application 61793657 · Mar 15, 2013
Related Publication 20160320382A1 · Nov 3, 2016